Review · Plant physiology and biochemistry · 2024Conflicts declared

Barley hordeins and ultra-low gluten barley breeding

What it found

Barley hordeins are the gluten proteins that trigger reactions in people with celiac disease and non-celiac gluten sensitivity.

Researchers have bred barley mutants with very low hordein levels, and new genomic techniques could help move these traits into more barley varieties.

What they found

Studies in people

Hordeins and reactions

Hordeins are the gluten proteins in barley. They trigger adverse reactions in people with celiac disease or non-celiac gluten sensitivity.

Beta-glucan and health

Barley contains beta-glucan, a dietary fibre that can help lower cholesterol and reduce the risk of cardiovascular diseases and diabetes. Some low-hordein mutants have low beta-glucan levels, which is unwanted for food use.

Animal and lab studies

Low-hordein barley mutants

Barley mutants with missing or reduced hordeins have been produced through traditional breeding and genetic modification. Some mutants have undesirable traits like lower yield and shrunken kernels.

Other findings

Peptides linked to celiac

The authors identified 105 hordein peptides connected to celiac disease. Most of these peptides bind to the HLA-DQ2 receptor.

Ultra-low gluten barley

Researchers developed an ultra-low gluten barley line called Kebari that has gluten content under 5 ppm. It took 14 years to develop and is limited to beer-making barley.

New genomic techniques

New genomic techniques like CRISPR and bridgeRNA could speed up the transfer of ultra-low gluten traits to other barley cultivars. They could also help remove unwanted traits from existing mutants.

What the authors conclude

  • They conclude that new genomic techniques, especially bridgeRNA-based genome editing, could accelerate the transfer of ultra-low gluten traits to other barley cultivars.
  • They suggest that patients with celiac disease should have access to barley's beneficial health traits, like beta-glucan, without the risk of consuming gluten.
  • They advise that creating non-allergenic hordein proteins would be an endless endeavour due to the sheer number of possible epitopes and peptides, so deleting hordeins or developing new therapeutics may be more feasible.

How it was done

Barley is a major global cereal, but its hordeins cause adverse reactions in people with celiac disease and non-celiac gluten sensitivity. The only current treatment for these conditions is a gluten-free diet, which limits grain-based food and drink choices.

The authors reviewed existing research on barley hordeins, including their genetic locations and the peptides linked to celiac disease. They also examined breeding work that produced barley mutants with reduced or missing hordeins, and they assessed how new genomic techniques could be used to develop barley lines with ultra-low gluten.

What it can’t tell you

  • This is a review of existing research, not a new study in people. It cannot show whether ultra-low gluten barley is safe for people with celiac disease or non-celiac gluten sensitivity.
  • The paper does not report long-term health outcomes from eating ultra-low gluten barley in people.

The paper

Title
Barley's gluten challenge: A path to hordein-free food and malt
Type
ReviewThe authors read earlier studies and describe what they found. It isn’t a new study.
Evidence
Studies in people · animals · lab
Summarised from
Full text
Cite
Hanak T, Andrzejczak OA, Hebelstrup K, Brinch-Pedersen H (2024). Barley's gluten challenge: A path to hordein-free food and malt. Plant physiology and biochemistry. doi:10.1016/j.plaphy.2024.109174Free full textPubMed 39362126DOI

Summary written 26 Sep 2026. Check it against the paper before it changes what you eat. How we summarise papers · Report an error